Regeneron recently announced it would initiate a quarterly dividend of $0.88, a competitive amount for a company first ...
Markets are tanking on tariff fears, inflationary concerns and now fears of recession. “Given this is so uncertain and that ...
Jones Financial Companies Lllp increased its stake in shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) ...
Leerink Partners 2025 Global Healthcare Conference Call March 11, 2025 8:00 AM ET. Company Participants. Ryan Crowe - SVP, IR & Strat ...
Hosted on MSN14d
Regeneron: Is It the Perfect Biotech Stock for Value and Growth?Regeneron Pharmaceuticals Inc. (NASDAQ ... The company also announced its first-ever dividend and authorized another $3 ...
Regeneron is now a dividend-paying company. The stock has lagged the market over the last year, and that remains true after the post-earnings rise. Where to invest $1,000 right now? Our analyst ...
The figure also surpassed the Zacks Consensus Estimate of $44.96. Regeneron initiated a quarterly cash dividend program and declared a dividend of $0.88 per share. The dividend is payable on March ...
Yes, its dividend yield is not that great at the moment, but Regeneron's financial policy reminds me of AstraZeneca (AZN), which first seeks to strengthen its presence in fast-growing therapeutic ...
NEW YORK, NY / ACCESS Newswire / March 10, 2025 / If you suffered a loss on your Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) investment and ...
Regeneron Pharmaceuticals (REGN) and Sanofi (SNY) presented positive results from the pivotal ADEPT Phase 2/3 trial evaluating the ...
Regeneron initiated a quarterly dividend per share that looks somewhat attractive. Despite some recent issues, the biotech company's business remains solid. Regeneron's share repurchase program ...
Detailed price information for Regeneron Pharmaceuticals (REGN-Q) from The Globe and Mail including charting and trades.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results